| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.16 | 0.2 |